Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities

Journal: ACS Nano

Published: 2020-05-07

DOI: 10.1021/acsnano.0c02633

Affiliations: 4

Authors: 15

Go to article
Institutions Share
Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development (MTDD), ECNU, China 0.53
Institute of Biomedical Engineering and Technology, ECNU, China 0.40
Shanghai East Hospital, Tongji University, China 0.07